PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.20%
Revenue growth above 1.5x NEM's 3.22%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-7.24%
Negative gross profit growth while NEM is at 12.80%. Joel Greenblatt would examine cost competitiveness or demand decline.
46.83%
EBIT growth above 1.5x NEM's 15.37%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
46.83%
Operating income growth above 1.5x NEM's 15.37%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
22.02%
Net income growth under 50% of NEM's 61.90%. Michael Burry would suspect the firm is falling well behind a key competitor.
16.67%
EPS growth under 50% of NEM's 55.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
No Data
No Data available this quarter, please select a different quarter.
10.24%
Share count expansion well above NEM's 3.81%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
10.44%
Diluted share count expanding well above NEM's 3.81%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
14.42%
OCF growth under 50% of NEM's 31.01%. Michael Burry might suspect questionable revenue recognition or rising costs.
27.48%
Positive FCF growth while NEM is negative. John Neff would see a strong competitive edge in net cash generation.
75.71%
Similar 10Y revenue/share CAGR to NEM's 83.76%. Walter Schloss might see both firms benefiting from the same long-term demand.
No Data
No Data available this quarter, please select a different quarter.
-36.46%
Negative 3Y CAGR while NEM stands at 12.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
936.18%
5Y OCF/share CAGR above 1.5x NEM's 100.28%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-41.26%
Negative 3Y OCF/share CAGR while NEM stands at 38.27%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
657.46%
5Y net income/share CAGR similar to NEM's 680.61%. Walter Schloss might see both on parallel mid-term trajectories.
-46.67%
Negative 3Y CAGR while NEM is 74.16%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
2332.51%
5Y equity/share CAGR above 1.5x NEM's 16.65%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
60.11%
Positive short-term equity growth while NEM is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
220.52%
Our AR growth while NEM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
13.22%
Asset growth above 1.5x NEM's 6.38%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.70%
BV/share growth above 1.5x NEM's 1.27%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-4.54%
We’re deleveraging while NEM stands at 1.99%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.31%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.